NCT06932484 (DELTA) is a NA clinical trial of parameters in Hemodynamic MAP Stability, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Who is sponsoring NCT06932484?

NCT06932484 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

What drugs are being tested in NCT06932484?

Interventions in NCT06932484: parameters.

What condition does NCT06932484 study?

NCT06932484 studies Hemodynamic MAP Stability.

Is NCT06932484 still recruiting?

NCT06932484 is currently recruiting now. Last updated 31 July 2025.

Last reviewed 2025-07-31 · How we verify

NCT06932484: DELTA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delta Variation to Guide Hemodynamic Optimization

Recruiting now NA Last updated 31 July 2025

What this trial tests

NA trial testing parameters in Hemodynamic MAP Stability in 104 participants. Currently enrolling.

Timeline

1 June 2025

Primary endpoint
1 May 2026

1 June 2027

Quick facts

Lead sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	104
Start date	1 June 2025
Primary completion	1 May 2026
Estimated completion	1 June 2027
Sites	1 location across Italy

Drugs / interventions tested

parameters

Conditions studied

Hemodynamic MAP Stability — all drugs for Hemodynamic MAP Stability →

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

18 and older, any sex, with Hemodynamic MAP Stability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

intraoperative hemodynamic optimization will be based on the percentage of variation of the parameters

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06932484 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Last refreshed: 31 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06932484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing